Skip to content

Therapeutic evaluation of Unani formulations and leeching in patients of Psoriasis

Randomized comparative clinical trial to evaluate the efficacy and safety of unani formulations and a classical regimen (Hirudotherapy) in Plaque Psoriasis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037022
Enrollment
60
Registered
2021-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS- Health Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: Pharmacopeal Unani formulations both systemic and topical: Group 2 will be given a Unani pharmacopeal preparation both oral(6gm) and local twice daily for a period of 6 months to compar

Sponsors

Department of Amraze jild wa Zohrawiya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of plaque psoriasis controlled clinically Clinically stable patients Patients having age group of 14-60 years Patients of either sex Patients not on any concomitant therapy Patients who has left the treatment at least 2 months back Patients agreed and signed the written consent proforma

Exclusion criteria

Exclusion criteria: Doubtful cases of plaque psoriasis Plaque psoriasis with systemic illnesses like diabetes mellitus, chronic liver diseases etc. Plaque psoriasis with secondary infection Immunocompromised patients Patients below the age of 14 years and above the age of 60 years

Design outcomes

Primary

MeasureTime frame
Improvement in erythema, scaling, itching and thickness of lesions.Timepoint: Improvement in itching - 4 weeks Improvement in erythema, scaling and thickness of lesions - 8 weeks

Secondary

MeasureTime frame
PASI score PGATimepoint: Monthly interval for a period of 6 months

Countries

India

Contacts

Public ContactDr Mohammad Mohsin

AMU

aqdas2005@gmail.com9412329198

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026